SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-346431
Filing Date
2013-08-26
Accepted
2013-08-26 14:12:53
Documents
1
Group Members
ARNOLD L. ORONSKYBRUCE CLEVELANDDOUGLAS A. PEPPERGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS IX, L.L.C.KHALED NASRNINA S. KJELLSONPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d588556dsc13da.htm SC 13D/A 272050
  Complete submission text file 0001193125-13-346431.txt   273879
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Subject) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85614 | Film No.: 131060077
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A